发明申请
US20130030185A1 CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND
有权
4- [2-（2-氟甲氧基甲基）苯基]哌啶化合物的晶体形式
![CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND](/docs/US/2013-01-31/US20130030185A1/abs.jpg.600x600.jpg)
- 专利标题： CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND
- 专利标题（中）： 4- [2-（2-氟甲氧基甲基）苯基]哌啶化合物的晶体形式
-
申请号： US13632588申请日： 2012-10-01
-
公开(公告)号： US20130030185A1公开(公告)日： 2013-01-31
- 发明人: Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- 申请人： Lori Jean Patterson , Robert S. Chao , Miroslav Rapta
- 申请人地址： US CA South San Francisco
- 专利权人： THERAVANCE, INC.
- 当前专利权人： THERAVANCE, INC.
- 当前专利权人地址： US CA South San Francisco
- 主分类号： C07D211/22
- IPC分类号： C07D211/22
![CRYSTALLINE FORM OF A 4-[2-(2-FLUOROPHENOXYMETHYL)PHENYL]PIPERIDINE COMPOUND](/abs-image/US/2013/01/31/US20130030185A1/abs.jpg.150x150.jpg)
摘要：
The invention provides a crystalline hydrochloride salt of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine. This invention also provides pharmaceutical compositions comprising the crystalline salt, processes and intermediates for preparing the crystalline salt, and methods of using the crystalline salt to treat diseases.
公开/授权文献
信息查询
